Clinical Trial

Phase III Trial of Concurrent Chemotherapy Alone in Patients With Low-risk Nasopharyngeal Carcinoma

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of this study is to compare concurrent chemoradiotherapy (CCRT) alone with induction chemotherapy (gemcitabine+cisplatin) plus CCRT in patients with low-risk locoregionally advanced nasopharyngeal carcinoma(NPC).
Protocol Amendment History 3 changes
critical Enrollment closed, study ongoing 2026-08-13
notable Primary completion pushed: 2026-09 -> 2029-03-05 2026-08-13
minor Completion pushed: 2029-09 -> 2031-03-05 2026-08-13
Trial Details
NCT Number NCT05979961
Lead Sponsor Sun Yat-sen University
Collaborators: First Affiliated Hospital of Guangxi Medical University, Zhongshan People's Hospital, Guangdong, China, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Tongji Hospital, Guangzhou Panyu Central Hospital, Hunan Cancer Hospital, Cancer Hospital of Guizhou Province
Conditions Nasopharyngeal Carcinoma
Enrollment 464 participants
Start Date 2023-09-07
Primary Completion 2029-03-05 (estimated)
Study Completion 2031-03-05 (estimated)
Updated on ClinicalTrials.gov 2026-08-12